HRTX Average Annual Return 10 Years
HRTX Average Annual Return Chart 10 Years
Growth of $10,000.00
Without Dividends Reinvested Into HRTX

Also see:
• HRTX stock yearly return 2014
• HRTX stock yearly return 2015
• HRTX stock yearly return 2016
• HRTX stock yearly return 2017
• HRTX stock yearly return 2018
• HRTX stock yearly return 2019
• HRTX stock yearly return 2020
• HRTX stock yearly return 2021
• HRTX stock yearly return 2022
• HRTX stock yearly return 2023
• HRTX YTD return
Average Annual Return Benchmarks
Compare HRTX average annual return versus benchmarks:

S&P Average Annual Return
Dow Average Annual Return
Nasdaq 100 Average Annual Return
Russell 2000 Average Annual Return
Gold Average Annual Return
10 Year Treasury Average Annual Return
HRTX Share Performance
HRTX Average Annual Return Table 10 Years
Start date: 12/05/2014
End date: 12/04/2024
Start price/share: $7.70
End price/share: $1.64
Dividends collected/share: $0.00
Total return: -78.70%
HRTX Average Annual Return: -14.32%
Starting investment: $10,000.00
Ending investment: $2,130.23
Years: 10.01


HRTX average annual return is presented with the assumption of reinvestments of any dividends on ex-date.
About Heron Therapeutics Inc
Heron Therapeutics, Inc. is a commercial-stage biotechnology company. Co. commercializes a portfolio of products to care for acute care and oncology patients. Its oncology care product portfolio includes SUSTOL and CINVANTI. SUSTOL is used for the prevention of acute and delayed nausea and vomiting associated with both moderately emetogenic chemotherapy (MEC), and anthracycline and cyclophosphamide (AC) combination chemotherapy regimens. CINVANTI is an intravenous (IV) formulation of aprepitant, a substance P/neurokinin-1 (NK1) receptor antagonist. Its acute care product portfolio includes ZYNRELEF and APONVIE. The HRTX average annual return 10 years is shown above.

The Average Annual Return on the HRTX average annual return 10 years page and across the coverage universe of our site, is a measure of the annualized return over the past ten years (or specified start date) for a given investment (up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window to capture long-term trends.

Thus, researching Average Annual Returns is good practice for investors — whether HRTX average annual return 10 years or other benchmarks/peers — and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors by performing the HRTX average annual return calculation with any dividends reinvested as applicable (on ex-dates).
HRTX Current Stock Quote
Quotes delayed 20 minutes

Email EnvelopeFree HRTX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
Featured Slideshows
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Don't Forget Dividends in Average Annual Return!
Video: Don't Forget Dividends in Average Annual Return!


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Average Annual Return Peers
Heron Therapeutics (HRTX) is categorized under the Healthcare sector; to help you further research average annual return performance across stocks, below are some other companies in the same sector:

HSCS Average Annual Return
HSDT Average Annual Return
HSIC Average Annual Return
HUMA Average Annual Return
HYPR Average Annual Return
IART Average Annual Return
IBRX Average Annual Return
ICAD Average Annual Return
ICCC Average Annual Return
ICLR Average Annual Return
More Healthcare companies »

What has the average annual return been for HRTX over the past ten years?
✔️Accepted answer: The ten year HRTX average annual return has been -14.32%.

What start date was used in your HRTX average annual return calculation?
✔️Accepted answer: The start date was 12/05/2014.

What end date was used in your HRTX average annual return calculation?
✔️Accepted answer: The end date was 12/04/2024.

If I had invested $10,000 into HRTX ten years ago, how much would I have today?
✔️Accepted answer: Today, as of 12/04/2024, you would have $2,130.23.

What does that work out to on a total return basis?
✔️Accepted answer: The HRTX ten year total return ending 12/04/2024 works out to -78.70%.


Also see:
• HRTX stock yearly return 2014
• HRTX stock yearly return 2015
• HRTX stock yearly return 2016
• HRTX stock yearly return 2017
• HRTX stock yearly return 2018
• HRTX stock yearly return 2019
• HRTX stock yearly return 2020
• HRTX stock yearly return 2021
• HRTX stock yearly return 2022
• HRTX stock yearly return 2023
• HRTX YTD return
 

HRTX Average Annual Return 10 Years | www.AverageAnnualReturn.com | Copyright © 2021 - 2024, All Rights Reserved

Nothing in AverageAnnualReturn.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.